Clinical trial

D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)

NCT00143702

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention d4T Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Abacavir Normalized identity: abacavirView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Riboflavin and Thiamine (Supplementation) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-08-01

PhasePHASE2 / PHASE3

Conditions

Acidosis, Lacticunresolved

Interventions

d4TDRUG

AbacavirDRUG · verified · RxNorm: abacavir

Riboflavin and Thiamine (Supplementation)DRUG

Sponsors & collaborators

University of British Columbialead sponsor

GlaxoSmithKlinecollaborator

CIHR Canadian HIV Trials Networkcollaborator

Mapped research locations

TorontoOntario, Canada1 VancouverBritish Columbia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00143702 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.